Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.
Laura De LucaMaria KalafateliSimone BianchiNorah AlasakerElena BuzzettiManuel Rodríguez-PerálvarezDouglas ThorburnJames O'BeirneDavid PatchGioacchino LeandroRachel WestbrookEmmanuel A TsochatzisPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Post-LT patients are at increased risk of CVS morbidity even in the absence of pre-existing metabolic risk factors. Renal sparing immunosuppressive protocols might reduce CVS events post-LT.